Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Pasithea Therapeutics Corp. | 152,783 | reported | 01 May 2026 | tx 17+1,371,203 |
| ETHZilla Corp | 110,000 | reported | 17 Jun 2025 | tx 11+468,958 |
| BioAtla, Inc. | 78,459 | reported | 18 Jun 2025 | tx 11+147,695−1,800 |
| NEUROCRINE BIOSCIENCES INC | 12,000 | reported | 26 May 2004 | tx 1+12,000 |
| Atreca, Inc. | 0 | reported | 24 Jun 2019 | tx 2+8,405−8,405 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | GRANT_AWARD | Pasithea Therapeutics Corp. | 152,783 | 0.00 USD | deriv |
| 28 Nov 2025 | PURCHASE | Pasithea Therapeutics Corp. | 133,333 | 0.75 USD | first after silence |
| 24 Oct 2025 | GRANT_AWARD | Pasithea Therapeutics Corp. | 242,913 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | ETHZilla Corp | 48,198 | 0.00 USD | |
| 17 Jun 2025 | GRANT_AWARD | ETHZilla Corp | 110,000 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | BioAtla, Inc. | 23,500 | 0.00 USD | |
| 20 Feb 2025 | GRANT_AWARD | ETHZilla Corp | 65,000 | 0.00 USD | |
| 13 Jun 2024 | GRANT_AWARD | BioAtla, Inc. | 16,500 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Pasithea Therapeutics Corp. | 7,500 | 0.00 USD | deriv |
| 19 Dec 2023 | PURCHASE | BioAtla, Inc. | 20,000 | 2.05 USD | |
| 04 Sept 2023 | GRANT_AWARD | ETHZilla Corp | 15,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | BioAtla, Inc. | 50,000 | 0.00 USD | deriv |
| 02 Jun 2023 | PURCHASE | Pasithea Therapeutics Corp. | 30,000 | 0.43 USD | |
| 01 Jun 2023 | PURCHASE | ETHZilla Corp | 18,000 | 1.23 USD | first after silence |
| 28 Nov 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 5,000 | 0.98 USD | |
| 22 Nov 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 5,000 | 0.99 USD | |
| 26 Oct 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 5,000 | 1.10 USD | |
| 17 Oct 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 1,000 | 1.14 USD | |
| 17 Oct 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 9,000 | 1.13 USD | |
| 28 Jun 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 5,000 | 1.02 USD | |
| 29 Jun 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 5,000 | 1.00 USD | |
| 27 Jun 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 5,000 | 1.00 USD | |
| 23 Jun 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 5,000 | 1.00 USD | |
| 21 Jun 2022 | GRANT_AWARD | Pasithea Therapeutics Corp. | 652,174 | 0.00 USD | |
| 02 Aug 2021 | GRANT_AWARD | Pasithea Therapeutics Corp. | 100,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 28 Nov 2025.